KRAS and lung carcinoma: In addition to MIA-PaCa2 cells, they have also tested the AMG 510 resistance in SW1463 human Caucasian rectum adenocarcinoma, LU99 lung giant cell carcinoma, and LU65 lung carcinoma cell lines which have KRAS G12C mutations.